Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Identification of Tractable Drug-like eIF4Al Inhibitors with Potent Anti-Tumor Activity

Tyler A. Cunningham, BS, Derek Essegian, BS, MS, Stephan Schürer, PhD, Jonathan H. Schatz, MD

Blood (2019) 134 (Supplement_1): 5760.

https://doi.org/10.1182/blood-2019-130494

Published: 2019

Journal Articles

Molecular Classification of Small B-Cell Lymphomas Using Digital Multiplexed Gene Expression Applicable to Formalin-Fixed Paraffin-Embedded Tissues

Min Xiao, MD PhD, Jianfeng Zhou, MD PhD, Wei Zhang, MD

Blood (2019) 134 (Supplement_1): 5770.

https://doi.org/10.1182/blood-2019-130446

Published: 2019

Journal Articles

Molecular Classification of AML-MRC Reveals a Distinct Profile and Identifies MRC-like Patients with Poor Overall Survival

Constance Baer, PhD, Wencke Walter, PhD, Anna Stengel, PhD, Stephan Hutter, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2019) 134 (Supplement_1): 2735.

https://doi.org/10.1182/blood-2019-128234

Published: 2019

Journal Articles

Peripheral Blood Cell Sorting Strategies for Transcriptomic Analysis in Chronic Myelomonocytic Leukemia

Moritz Binder, MDMPH, Ryan Carr, MD PhD, Nathalie Droin, PhD, Abhishek A Mangaonkar, MBBS, Giacomo Coltro, MD, Luciana L Almada, PhD, David Marks, PhD, Kurt Berger, Terra Lasho, PhD, Naseema Gangat, MBBS, Christopher Pin, PhD, Martin Fernandez-Zapico, MD, Eric Solary, MD PhD, Mrinal M Patnaik, MDMBBS

Blood (2019) 134 (Supplement_1): 4232.

https://doi.org/10.1182/blood-2019-122187

Published: 2019

Journal Articles

Computational Identification of Tractable Drug-like Inhibitors of eIF4A1

Derek Essegian, BS, MS, Tyler A. Cunningham, BS, Jonathan H. Schatz, MD, Stephan Schurer, PhD

Blood (2018) 132 (Supplement 1): 5802.

https://doi.org/10.1182/blood-2018-99-116829

Published: 2018

Journal Articles

Clinical and Molecular Models of Prognostication in Mastocytosis: Analysis Based on 580 Consecutive Cases

Animesh Pardanani, MBBS, PhD, Yoseph Elala, MD, Sahrish Shah, MD, Terra L. Lasho, PhD, Mrinal M. Patnaik, MDMBBS, Darci Zblewski, APRN, C-NP, Rhett P. Ketterling, Curtis A. Hanson, MD, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 582.

https://doi.org/10.1182/blood-2018-99-113914

Published: 2018

Journal Articles

Clinical Correlates, Prognostic Impact and Survival Outcomes in Chronic Myelomonocytic Leukemia Patients with Myeloproliferative Neoplasm Associated-Driver Mutations

Prateek Pophali, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Pedro Horna, MD, Rhett P. Ketterling, Naseema Gangat, MBBS, Kebede H. Begna, MD, Abhishek A. Mangaonkar, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Mrinal M. Patnaik, MD MBBS

Blood (2018) 132 (Supplement 1): 3100.

https://doi.org/10.1182/blood-2018-99-117335

Published: 2018

Journal Articles

Unique Transmembrane Domain Interactions Differentially Modulate Platelet αIIbβ3 and αvβ3 Function

Rustem I. Litvinov, MD PhD, Marco Mravic, B.S., M.S., Hua Zhu, BS, John W. Weisel, PhD, William F. DeGrado, PhD, Joel S. Bennett, MD

Blood (2017) 130 (Supplement 1): 1019.

https://doi.org/10.1182/blood.V130.Suppl_1.1019.1019

Published: 2017

Journal Articles

Analysis of a Naturally Occurring PAR4 Variant By Hydrogen/Deuterium Exchange Reveals Its Structural Rearrangement upon Activation By Thrombin and the Molecular Basis for Altered Reactivity

Xu Han, BS, MS, Lukas Hofmann, PhD, Maria de la Fuente, BS, Tivadar Orban, PhD, Nathan Alexander, PhD, Krzysztof Palczewski, PhD, Marvin T Nieman, PhD

Blood (2017) 130 (Supplement 1): 453.

https://doi.org/10.1182/blood.V130.Suppl_1.453.453

Published: 2017

Journal Articles

Extramedullary Manifestations in World Health Organization-Defined Chronic Myelomonocytic Leukemia: Clinical, Molecular and Prognostic Correlates

Katherine Hoversten, MD, Rangit Vallapureddy, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Rhett P. Ketterling, MD, Curtis A. Hanson, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD, Mrinal M. Patnaik, MDMBBS

Blood (2017) 130 (Supplement 1): 4272.

https://doi.org/10.1182/blood.V130.Suppl_1.4272.4272

Published: 2017

Journal Articles

Number and Type of TET2 Mutations in Chronic Myelomonocytic Leukemia: Clinical and Prognostic Correlates

Mrinal M Patnaik, MBBS, Mohammad Faizan Zahid, Terra L. Lasho, PhD, Ezequiel Tolosa, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Eric Solary, MD Prof, Keith D Robertson, PhD, Naseema Gangat, MBBS, Martin E. Fernandez-Zapico, MD, Ayalew Tefferi, MD

Blood (2016) 128 (22): 4343.

https://doi.org/10.1182/blood.V128.22.4343.4343

Published: 2016

Journal Articles

Clinical Relevance of Driver Mutations and Number of Driver Mutations in Patients with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Blood (2016) 128 (22): 54.

https://doi.org/10.1182/blood.V128.22.54.54

Published: 2016

Journal Articles

"Proliferative" Versus "Dysplastic" Chronic Myelomonocytic Leukemia: Molecular and Prognostic Correlates

Mrinal M Patnaik, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Matthew T Howard, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 1987.

https://doi.org/10.1182/blood.V128.22.1987.1987

Published: 2016

Journal Articles

DNTM3A Mutations and Prognosis in Chronic Myelomonocytic Leukemia

Mrinal M Patnaik, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Matthew T Howard, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 1988.

https://doi.org/10.1182/blood.V128.22.1988.1988

Published: 2016

Journal Articles

Driver Somatic Mutations and Transplantation Decision Making in Patients with Myelodysplastic Syndrome

Blood (2016) 128 (22): 53.

https://doi.org/10.1182/blood.V128.22.53.53

Published: 2016

Journal Articles

Redesign of EAF Peg Hb As an Oxygen Transfer Catalyst for Improved Tissue Oxygenation of Hypoxic Areas: A Therapeutic for Anemia and Sickle Cell Disease

Savita Bhutoria, PhD, Amy Tsai, PhD, Marcos Intaglietta, PhD, Sandra M. Suzuka, MS, Sangeetha Thangaswamy, PhD, Prabhakaran Muthuchidambaram, PhD, Caterina Minniti, MD, Henny Heisler H Billett, MD, Craig A Branch, PhD, Seetharama A Acharya, PhD

Blood (2016) 128 (22): 4845.

https://doi.org/10.1182/blood.V128.22.4845.4845

Published: 2016

Journal Articles

Incorporation of Molecular Data into the Current Prognostic Models in Treated Patients with Myelodysplastic Syndromes: Which Model Is the Best

Karam Al-Issa, MD, Ahmad Zarzour, MD, Tomas Radivoyevitch, PhD, Matt Kalaycio, MD, Betty K. Hamilton, MD, Aaron T. Gerds, MD MS, Sudipto Mukherjee, MD, PhD, M.P.H., Vera Adema, PhD, Michael J. Clemente, M.S., Bhumika Patel, MD, Cassandra M. Hirsch, BSc, Anjali S. Advani, MD, Bartlomiej P Przychodzen, MSc, Hetty E. Carraway, MD MBA, Jaroslaw P Maciejewski, MD PhD FACP, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD

Blood (2016) 128 (22): 50.

https://doi.org/10.1182/blood.V128.22.50.50

Published: 2016

Journal Articles

Structural Basis for the Procofactor to Cofactor Transition in Human Factor V

Shekhar Kumar, PhD, Wei Deng, PhD, Steven Stayrook, PhD, Renhao Li, PhD, Rodney M. Camire, PhD, Sriram Krishnaswamy, PhD

Blood (2016) 128 (22): 253.

https://doi.org/10.1182/blood.V128.22.253.253

Published: 2016

Journal Articles

The Hunt for the "Minimal" Structure of a Functional ADAMTS13: Study of Deletion Mutations of ADAMTS13 By Small-Angle X-Ray Scattering

Jian Zhu, PhD, Joshua Muia, PhD, Louis Deforche, PhD, Karen Vanhoorelbeke, PhD, Niraj H. Tolia, PhD, J. Evan Sadler, MD PhD

Blood (2016) 128 (22): 254.

https://doi.org/10.1182/blood.V128.22.254.254

Published: 2016

Journal Articles

Sf3b1 K700E Mutation Impairs Pre-mRNA Splicing and Definitive Hematopoiesis in a Conditional Knock-in Mouse Model

Annalisa Mupo, PhD, Vijitha Sathiaseelan, Michael Seiler, PhD, David Kent, PhD, Shouyong Peng, PhD, Ruben Bautista, Suruchi Pacharne, Barry Rosen, Manousos Koutsourakis, Nicla Manes, Frances Law, Elli Papaemmanuil, PhD, Silvia Buonamici, PhD, Peter J Campbell, MD PhD, Niccolo Bolli, MD PhD, George S. Vassiliou, MD PhD

Blood (2015) 126 (23): 140.

https://doi.org/10.1182/blood.V126.23.140.140

Published: 2015

NARROW

Identification of Tractable Drug-like eIF4Al Inhibitors with Potent Anti-Tumor Activity

Molecular Classification of Small B-Cell Lymphomas Using Digital Multiplexed Gene Expression Applicable to Formalin-Fixed Paraffin-Embedded Tissues

Molecular Classification of AML-MRC Reveals a Distinct Profile and Identifies MRC-like Patients with Poor Overall Survival

Peripheral Blood Cell Sorting Strategies for Transcriptomic Analysis in Chronic Myelomonocytic Leukemia

Computational Identification of Tractable Drug-like Inhibitors of eIF4A1

Clinical and Molecular Models of Prognostication in Mastocytosis: Analysis Based on 580 Consecutive Cases

Clinical Correlates, Prognostic Impact and Survival Outcomes in Chronic Myelomonocytic Leukemia Patients with Myeloproliferative Neoplasm Associated-Driver Mutations

Unique Transmembrane Domain Interactions Differentially Modulate Platelet αIIbβ3 and αvβ3 Function

Analysis of a Naturally Occurring PAR4 Variant By Hydrogen/Deuterium Exchange Reveals Its Structural Rearrangement upon Activation By Thrombin and the Molecular Basis for Altered Reactivity

Extramedullary Manifestations in World Health Organization-Defined Chronic Myelomonocytic Leukemia: Clinical, Molecular and Prognostic Correlates

Number and Type of TET2 Mutations in Chronic Myelomonocytic Leukemia: Clinical and Prognostic Correlates

Clinical Relevance of Driver Mutations and Number of Driver Mutations in Patients with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

"Proliferative" Versus "Dysplastic" Chronic Myelomonocytic Leukemia: Molecular and Prognostic Correlates

DNTM3A Mutations and Prognosis in Chronic Myelomonocytic Leukemia

Driver Somatic Mutations and Transplantation Decision Making in Patients with Myelodysplastic Syndrome

Redesign of EAF Peg Hb As an Oxygen Transfer Catalyst for Improved Tissue Oxygenation of Hypoxic Areas: A Therapeutic for Anemia and Sickle Cell Disease

Incorporation of Molecular Data into the Current Prognostic Models in Treated Patients with Myelodysplastic Syndromes: Which Model Is the Best

Structural Basis for the Procofactor to Cofactor Transition in Human Factor V

The Hunt for the "Minimal" Structure of a Functional ADAMTS13: Study of Deletion Mutations of ADAMTS13 By Small-Angle X-Ray Scattering

Sf3b1 K700E Mutation Impairs Pre-mRNA Splicing and Definitive Hematopoiesis in a Conditional Knock-in Mouse Model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only